Detailed Information

Cited 0 time in webofscience Cited 0 time in scopus
Metadata Downloads

Differential anti-ischemic efficacy and therapeutic time window of trans- and cis-hinokiresinols: Stereo-specific antioxidant and anti-inflammatory activities

Authors
Ju, ChungHwang, SunyoungCho, Geum-SilKondaji, GajulapatiSong, SumiPrather, Paul L.Choi, YongseokKim, Won-Ki
Issue Date
4월-2013
Publisher
PERGAMON-ELSEVIER SCIENCE LTD
Keywords
Hinokiresinol; Oxygen-glucose deprivation; Middle cerebral artery occlusion; Antioxidant; Anti-inflammation; Therapeutic window; Stereo-specificity
Citation
NEUROPHARMACOLOGY, v.67, pp.465 - 475
Indexed
SCIE
SCOPUS
Journal Title
NEUROPHARMACOLOGY
Volume
67
Start Page
465
End Page
475
URI
https://scholar.korea.ac.kr/handle/2021.sw.korea/103695
DOI
10.1016/j.neuropharm.2012.12.006
ISSN
0028-3908
Abstract
During cerebral ischemia, neurons are injured by various mechanisms including excitotoxicity, oxidative stress, and inflammatory responses. Thus, pharmacological manipulation of multiple cytotoxic pathways has been pursued for the treatment of ischemic injury. Cis-hinokiresinol, a naturally occurring phenylpropanoid, was previously reported to possess anti-oxidant, anti-inflammatory and estrogen-like activities. In the present study, we investigated anti-ischemic effects of trans- and cis-hinokiresinols using in vitro as well as in vivo experimental models. The ORAC and DPPH assays showed that two isomers had similar free radical scavenging activities. However, only trans-hinokiresinol significantly decreased neuronal injury in cultured cortical neurons exposed to oxygen-glucose deprivation (75 min) followed by re-oxygenation (9 h). The differential neuroprotective effect could be due to the stereo-specific augmentation of Cu/Zn-SOD activity by trans-hinokiresinol, when compared with cis-hinokiresinol. Similarly, in rats subjected to transient middle cerebral artery occlusion (1.5 h) followed by 24-h reperfusion, pre-ischemic treatment with trans-hinokiresinol, but not with cis-isomer, reduced cerebral infarct volume. Interestingly, however, post-ischemic treatment with both hinokiresinols (2 and 7 h after onset of ischemia) significantly reduced cerebral infarct. When administered after onset of ischemia, trans-hinokiresinol, but not its cis-isomer reduced nitrotyrosine immunoreactivity in ischemic regions. In contrast, both hinokiresinols suppressed neutrophil infiltration and IL-1 beta release to a similar extent. The observed differential anti-oxidant, but comparable anti-inflammatory, activities may explain the stereospecific anti-ischemic activities and different therapeutic time windows of the hinokiresinols examined. More detailed delineation of the anti-ischemic mechanism(s) of hinokiresinols may provide a better strategy for development of efficacious regimens for cerebral ischemic stroke. (c) 2012 Elsevier Ltd. All rights reserved.
Files in This Item
There are no files associated with this item.
Appears in
Collections
Graduate School > Department of Biotechnology > 1. Journal Articles
Graduate School > Department of Biomedical Sciences > 1. Journal Articles

qrcode

Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.

Related Researcher

Researcher Choi, Yong seok photo

Choi, Yong seok
생명과학대학 (생명공학부)
Read more

Altmetrics

Total Views & Downloads

BROWSE